DopaGE

DopaGE is a pre-clinical stage biotechnology company focused on developing a transformative gene therapy for Parkinson's disease. The company's core technology involves a proprietary gene delivery system designed to restore dopamine production in the brain by targeting specific neuronal pathways. By utilizing a localized and regulated approach, DopaGE aims to provide a long-term solution that mitigates the motor symptoms of Parkinson's while reducing the side effects associated with traditional oral levodopa treatments. The company is currently advancing its lead program through IND-enabling studies to transition into clinical trials.